AP26113-11-101

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113


MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit 087
Houston, TX 77030

University of Chicago
5841 South Maryland Avenue
Chicago, IL 60637
773-834-7424

University of Colorado
1380 Lawrence Street
PO Box 173364 Campus Box 167
Aurora, CO 80045

Abramson Cancer Center of The University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
215-662-7013

Yale University
333 Cedar Street
New Haven, CT 06520
203-785-2604

Massachusetts General Hospital Cancer Center
55 Fruit Street
Boston, MA 02114

University of California At San Diego
200 West Arbor Drive
La Jolla, CA 92093
858-822-7894

Hospital Universitari Germans Trias i Pujol
Barcelona 08916